Cargando…
Voiding Dysfunction Due to Urethral Sphincter Dysfunction Might Be an Early Neurological Presentation of Central Nervous System Disorders in Aged Patients
Purpose: To investigate the incidence of central nervous system (CNS) diseases in adult patients with voiding dysfunction and videourodynamics (VUDS) proven urethral sphincter dysfunction. Methods: This retrospective analysis reviewed the medical charts of patients aged > 60 years who underwent V...
Autores principales: | Ho, Guan-Ru, Wei, Chiao-Wen, Kuo, Hann-Chorng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142522/ https://www.ncbi.nlm.nih.gov/pubmed/37109078 http://dx.doi.org/10.3390/jpm13040693 |
Ejemplares similares
-
Therapeutic Effects of Botulinum Toxin A, via Urethral Sphincter Injection on Voiding Dysfunction Due to Different Bladder and Urethral Sphincter Dysfunctions
por: Lee, Yu-Khun, et al.
Publicado: (2019) -
The Therapeutic Effects and Pathophysiology of Botulinum Toxin A on Voiding Dysfunction Due to Urethral Sphincter Dysfunction
por: Kao, Yao-Lin, et al.
Publicado: (2019) -
Botulinun A toxin urethral sphincter injection for neurogenic or nonneurogenic voiding dysfunction
por: Kuo, Hann-Chorng
Publicado: (2016) -
Real-World Data Regarding Satisfaction to Botulinum Toxin A Injection into the Urethral Sphincter and Further Bladder Management for Voiding Dysfunction among Patients with Spinal Cord Injury and Voiding Dysfunction
por: Lee, Cheng-Ling, et al.
Publicado: (2022) -
OnabotulinumtoxinA Urethral Sphincter Injection as Treatment for Non-neurogenic Voiding Dysfunction – A Randomized, Double-Blind, Placebo-Controlled Study
por: Jiang, Yuan-Hong, et al.
Publicado: (2016)